Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Transcaval Access and Closure for Transcatheter Aortic Valve Replacement

Open access
Greenbaum, Adam B., Babaliaros, Vasilis C., Chen, Marcus Y., Stine, Annette M., Rogers, Toby, O’Neill, William W., Paone, Gaetano, Thourani, Vinod H., Muhammad, Kamran I., Leonardi, Robert A., Ramee, Stephen, Troendle, James F., Lederman, Robert J. · 2017 · Journal of the American College of Cardiology

Abstract

Background Transcaval access may enable fully percutaneous transcatheter aortic valve replacement (TAVR) without the hazards and discomfort of transthoracic (transapical or transaortic) access. Objectives We performed a prospective, independently-adjudicated, multi-center, single-arm Investigational Device Exemption trial of transcaval access for TAVR in patients ineligible for femoral artery access and high or prohibitive risk of complications from transthoracic access. Methods 100 subjects underwent attempted percutaneous transcaval access to the abdominal aorta by electrifying a caval guidewire and advancing into a prepositioned aortic snare. After exchanging for a rigid guidewire, conventional TAVR was performed through transcaval introducer sheaths. Transcaval access ports were closed with nitinol cardiac occluders. A core lab analyzed pre-discharge and 30-day abdominal CT. The STS predicted risk of mortality was 9.6 ± 6.3%. Results Transcaval access was successful in 99/100 subjects. Device success (access and closure with a nitinol cardiac occluder without death or emergency surgical rescue) was 98/99, except for one closed only with a covered stent. Inpatient survival was 96% and 30-day survival was 92%. VARC2 life-threatening bleeding and modified VARC2 major vascular complications possibly related to transcaval access were 7% and 13%, respectively. Median length of stay was 4 (2–6) days. There were no vascular complications after discharge. Conclusion Transcaval access enabled TAVR in patients who were not good candidates for transthoracic access. Bleeding and vascular complications, using permeable nitinol cardiac occluders to close the access ports, were common but acceptable in this high risk cohort. Transcaval access should be investigated in patients who are eligible for transthoracic access. Purpose-built closure devices are in development that may simplify the procedure and reduce bleeding. Clinical trial NCT02280824 on clinicaltrials.gov

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2016.10.024

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 226

Metadata

Authors
Greenbaum, A. B., Babaliaros, V. C., Chen, M. Y., Stine, A. M., Rogers, T., O’Neill, W. W., Paone, G., Thourani, V. H., Muhammad, K. I., Leonardi, R. A., Ramee, S., Troendle, J. F., & Lederman, R. J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2017-02
Volume
69
Issue
5
Pages
511-521
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2540681191
Cited by
226
References
3
FWCI
21.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcaval Access and Closure for Transcatheter Aortic Valve Replacement. https://app.cochat.ai/papers/10.1016/j.jacc.2016.10.024
The paper
Greenbaum, A. B., Babaliaros, V. C., Chen, M. Y., Stine, A. M., Rogers, T., O’Neill, W. W., Paone, G., Thourani, V. H., Muhammad, K. I., Leonardi, R. A., Ramee, S., Troendle, J. F., & Lederman, R. J. (2017). Transcaval Access and Closure for Transcatheter Aortic Valve Replacement. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2016.10.024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.